Biochemix Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 30.43%
- Ebitda 30.43%
- Net Worth -12.25%
- Total Assets -11.08%
About Biochemix Life Sciences
Biochemix Life Sciences Private Limited (BLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2015 (Nine years and eight months 8 days old ). Its registered office is in Chandigarh, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Arora and Deeksha Arora serve as directors at the Company.
Company Details
- Location Chandigarh, Chandigarh
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52399CH2015PTC035573
-
Company No.
035573
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jun 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Biochemix Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Arora
|
Director | 10-Jun-2015 | Current |
|
Deeksha Arora
|
Director | 01-Mar-2018 | Current |
Financial Performance of Biochemix Life Sciences.
Biochemix Life Sciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biochemix Life Sciences?
In 2021, Biochemix Life Sciences had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bonafide Nutrition Private LimitedNeeraj Arora and Deeksha Arora are mutual person
-
Biochemix Healthcare Private LimitedNeeraj Arora is a mutual person
-
Accura Care Pharmaceuticals Private LimitedNeeraj Arora and Deeksha Arora are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biochemix Life Sciences?
Unlock and access historical data on people associated with Biochemix Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biochemix Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biochemix Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
